NovoTTF-200A + Pembrolizumab In Melanoma Brain Metastasis
Brown University
Brown University
Therakos LLC
City of Hope Medical Center
Hadassah Medical Organization
Mayo Clinic
Indiana University
Case Comprehensive Cancer Center
Massachusetts General Hospital
Massachusetts General Hospital
Thomas Jefferson University
Thomas Jefferson University
ImmunityBio, Inc.
ImmunityBio, Inc.
Mayo Clinic
University of Kansas Medical Center
European Institute of Oncology
Immunocore Ltd
Medical University of Graz
TJ Biopharma Co., Ltd.
Johns Hopkins University
University of Miami
Vastra Gotaland Region
Dana-Farber Cancer Institute
University of Louisville
Rain Oncology Inc
Northwestern University
Nova Scotia Cancer Centre
Fondazione Melanoma Onlus
Alliance for Clinical Trials in Oncology
Targovax ASA
Providence Health & Services
Dana-Farber Cancer Institute
Excel Diagnostics and Nuclear Oncology Center
Pierre Fabre Medicament
Institut du Cancer de Montpellier - Val d'Aurelle
Rush University Medical Center
Presage Biosciences
Northwestern University
Northwestern University
Yale University
4SC AG
European Organisation for Research and Treatment of Cancer - EORTC
University of Wisconsin, Madison
Nektar Therapeutics
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Rochester General Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Turnstone Biologics, Corp.
Bristol-Myers Squibb
Samsung Medical Center